Inovio (INO) Pharmaceuticals announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares of common stock in the proposed offering will be sold by Inovio. Piper Sandler & Co. is acting as sole book-running manager for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INO:
- Inovio reports Q3 EPS (87c), consensus (48c)
- Options Volatility and Implied Earnings Moves Today, November 10, 2025
- Options Volatility and Implied Earnings Moves This Week, November 10 – November 14, 2025
- Is INO a Buy, Before Earnings?
- Inovio Pharmaceuticals: Hold Rating Amid Promising Developments and Significant Risks